We're exiting a troubled stock after a muted quarter, while considering better options

Jim Cramer's Charitable Trust plans to sell 1,600 Nike (NKE) shares at about $41 after another muted earnings report, exiting after Wednesday’s trade. The article cites inventory/markdown progress but says the turnaround remains slow and Greater China recovery is taking longer than expected, with competition weighing on the rebound. The sale comes as NKE’s position is being cut at an estimated 40% loss, with proceeds redeployed into other stocks while awaiting a possible Investor Day catalyst in November.

Analysis

The key issue is not this print; it’s the duration of the reset. When a large-cap brand loses momentum but can only point to a recovery several quarters out, the stock usually trades on multiple compression rather than near-term EPS revisions, because every month of delayed inflection pushes out the operating-leverage payoff. That creates a window where rivals with cleaner sell-through and less turnaround drag can take incremental shelf space and mindshare.

Second-order winners are the brands and retailers that can absorb share without having to cleanse their own inventory in public. In athletic footwear/apparel, that favors names with tighter product cycles and less legacy wholesale baggage, while multi-brand retailers dependent on traffic from the dominant franchise may see weaker basket conversion even if promotional intensity falls. The market may also be underestimating how much margin repair can coexist with softer demand: reducing markdowns helps gross margin, but if volume does not follow, the recovery can look optically better than the earnings power underneath.

Time horizon matters. Over the next 1-3 months, the setup is likely range-bound and headline-driven into the November event, with upside mainly coming from a clean-inventory narrative and downside if China or order trends fail to reaccelerate. Over 6-18 months, the question is whether this becomes a slower-growth, lower-multiple compounder rather than a true re-rating story; the thesis is falsified if management raises guidance, wholesale reorders improve materially, or China shows sustained acceleration.

Contrarian view: the market may be too focused on the near-term pain and not enough on the possibility of a tactical squeeze if the event is cleaner than feared. But even that would likely be a trading rally, not an earnings-cycle reset, unless demand growth becomes visible in the next two quarters.

Key Decisions for Investors

• Avoid chasing a long in NKE here; the cleaner expression is to wait for any rally into the November catalyst and fade strength with a short or a put spread if China/wholesale data remain soft.
• Pair trade: long LULU or ONON vs short NKE over the next 1-3 months to express share shift toward brands with better product velocity and less turnaround overhang.
• Set a watch alert on NKE at the low-40s/low-40s support zone; a decisive break lower without improving sell-through would confirm the stock is still a dead-money story.
• If taking options exposure, use a limited-risk bearish structure into the November event rather than outright short stock; the main risk is a tactical squeeze on inventory-cleanup headlines.